IP Library › Granted Patent US 11,898,189
Granted Patent B2
US 11,898,189 · App. 17/311,426 · Granted Feb 13, 2024

Microalgal strain and its use for the production of lipids

Inventors: Roberta Miglio (Novara, IT); Tomas Morosinotto (Desenzano del Garda, IT); Alessandra Bellan (Cavarzere, IT)
Assignee: ENI S.P.A.
C12P7/64C12N1/12C12R2001/89
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,898,189
App. No.
17/311,426
Granted
Feb 13, 2024
Kind
B2
Abstract

A microalgal strain of the species Nannochloropsis gaditana is characterized by a mutation of an enzyme involved in the biosynthesis of chlorophyll that changes the physiology thereof with respect to the wild-type strain of the same species. In particular, with the mutation, microalgae are formed which, with respect to the wild-type strain of the same species, have a lower chlorophyll content and a reduced capacity to absorb visible radiation (light). Further, a process for the production of lipids through the cultivation of the mutated Nannochloropsis gaditana strain and the lipids obtained can be used as synthesis intermediates, particularly in the so-called “green-chemistry” sector or in the production of biofuels.

Claims (15)

1. A microalgal strain of Nannochloropsis gaditana species deposited, in accordance with Budapest Treaty, at the Culture Collection of Algae and Protozoa (CCAP), Oban, access number CCAP 849/21.

2. A process for the production of lipids, the process including the following steps:

cultivating a Nannochloropsis gaditana CCAP 849/21 strain in a culture medium, under presence of visible radiation;

subjecting said culture to separation, obtaining an aqueous biomass suspension of Nannochloropsis gaditana CCAP 849/21 comprising intracellular lipids and an aqueous phase; and

extracting the intracellular lipids accumulated inside Nannochloropsis gaditana CCAP 849/21.

3. The process according to claim 2 , wherein said process for the production of lipids is carried out:

at a temperature ranging from 10° C. to 40° C.; and/or

under aerobic conditions; and/or

is carried out at a pH ranging from 4.5 to 9.5.

4. The process according to claim 2 , wherein said process for the production of lipids is carried out starting from an inoculum in an amount ranging from 0.1% to 10% (vol/vol) of the culture medium total volume, obtained from a previous culture of said Nannochloropsis gaditana CCAP 849/21 strain, carried out in the same culture medium for a time ranging from 6 hours to 72 hours.

5. The process according to claim 2 , wherein said process is carried out in a F/2 culture medium having sea salt, Tris-HCl, a Guillard (F/2) marine water enrichment solution, and nitrogen.

6. The process according to claim 2 , wherein said process for the production of lipids is carried out in a discontinuous mode or in a continuous mode.

7. The process according to claim 6 , wherein said process, after a time ranging from 15 hours to 175 hours after inoculation, is further carried out in the discontinuous mode or in the continuous mode, without time limit, adding at least one further source of nitrogen, in an amount such as adding to culture medium a nitrogen amount ranging from 0.02 g/l to 5 g/l.

8. The process according to claim 2 , wherein the step of subjecting the culture to separation is carried out by techniques selected from: flocculation, flotation, filtration, filter pressing, microfiltration, ultrafiltration, centrifugation or combinations thereof.

9. The process according to claim 2 , wherein the step of extracting the intracellular lipids is carried out by cellular lysis of Nannochloropsis gaditana CCAP 849/21 biomass.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2021
From: MOROSINOTTO, TOMAS; BELLAN, ALESSANDRA
To: ENI S.P.A.
Reel/Frame 056508/0833 →
Priority Claims (1)
IT 102018000010858 · Dec 6, 2018 · national
Continuity (1)
Related Publication 20220025414A1 · Jan 27, 2022